Researchers say hemorrhaging is the leading cause of death on the battlefield. But transporting replacement blood for ...
The Pentagon’s DARPA program has advanced a shelf-stable powdered blood substitute toward human trials, aiming to address battlefield and emergency transfusion challenges. The universal donor product ...
Chicago, IL - People treated with blood substitutes in clinical trials over the past two decades were 30% more likely to die and had almost a threefold higher rate of MI than patients in control ...